Journal of Thoracic Oncology

ournal of Thoracic Oncology (JTO), the official Journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.

Publisher
Lippincott Williams & Wilkins
Website
http://journals.lww.com/jto/pages/default.aspx

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Unique cells found in lung cancer patients may predict survival

Lung cancer is the leading cause of cancer-related deaths in the U.S. and most who are diagnosed with lung cancer do not survive five years. Non-small cell lung cancer (NSCLC) is the most common type where tumor cells shed ...

Oncology & Cancer

Molecular testing rates in most countries less than 50 percent

Access to targeted therapies for lung cancer depends on accurate identification of patients' biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international ...

Oncology & Cancer

Lung cancer trials supported by drug industry stronger

Lung cancer clinical trials supported by the pharmaceutical industry demonstrate no more bias compared to studies funded by other sources, according to a study published in the Journal of Thoracic Oncology, the official journal ...

page 1 from 16